Loading Events

« All Events

  • This event has passed.

BioPharma Investor Perspectives Workshop

April 10, 2015 @ 10:00 am - 5:00 pm

Cornerstone Capital Group’s John Wilson will participate in this event. 

A one-day interactive discussion and networking opportunity for senior biopharma Finance, Risk, and Sustainability officers to talk directly with financial market actors – analysts, portfolio managers, and asset managers – about sustainability performance and market value.

Gbola Amusa, Managing Director & Head of Healthcare Research at Chardan Capital Markets, will give the luncheon keynote, sharing an investor’s perspective on the value of sustainability in pharma and biotech.  Workshop session leaders include:

  • Thomas Scheiwiller, Independent Advisor at Scheiwiller Impacts, on Roundtable Survey outcomes and connecting biopharma and investor perspectives on sustainability
  • Olga Emelianova, VP ESG Research at MSCI, leading a panel on investor perspectives regarding material risks and opportunities in biopharma
  • John Spinnato, VP-NA for CSR & President, Sanofi Foundation NA, leading a panel on connecting sustainability with risk management, and embedding sustainability objectives in operational plans
  • John Wilson, Head of Governance, Engagement & Research, Cornerstone Capital, leading a wrap-up discussion on sustainable investing themes and challenges for the biopharma industry

For more details, visit the event registration page.

Read Cornerstone’s report from the 2014 Roundtable and Global Markets Strategist Michael Geraghty on BioPharma from an ESG perspective.


April 10, 2015
10:00 am - 5:00 pm
Event Categories:


7 World Trade Center
250 Greenwich Street
New York, NY United States
+ Google Map